Rapport Therapeutics Inc (RAPP)

NASDAQ · Pharmaceuticals

49.13
+0.12 (+0.25%)
Updated Aug 19, 5:45 PM ET
AI Rating
Buy
Overall Score
65
Trend
75
Momentum
88
Risk
18

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Rapport Therapeutics Inc is trading at $49.13, up 0.25% on the session. The 50 day average sits at $40.83 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 63.4, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $39.75 with resistance near $49.50, so that band frames the current range. Average daily movement is roughly $2.40, or about 4.9% of the share price, which is what any stop placement has to allow for. The overall health score of 65 out of 100 combines a trend score of 75, momentum of 88 and a risk score of 18.

Technical indicators

RSI (14)
63.4
strong
MACD
1.981
bullish crossover
SMA 20
43.53
SMA 50
40.83
SMA 200
--
unknown
ATR (14)
2.40
avg daily range
Support
39.75
Resistance
49.50
Volume vs 20d
0.52x
below average
Volatility
57.8%
annualised
1 month
+18.17%
3 months
+24.95%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.